Evaluation of an oral telomerase activator for early age-related macular degeneration - a pilot study
Open accessThe DOI matches its Crossref record; 55 of the 56 references it cites were found in a registry or an index.
Abstract
PURPOSE: Telomere attrition and corresponding cellular senescence of the retinal pigment epithelium contribute to the changes of age-related macular degeneration. Activation of the enzyme telomerase can add telomeric DNA to retinal pigment epithelium chromosomal ends and has been proposed as a treatment for age-related macular degeneration. We report the use of a small molecule, oral telomerase activator (TA)-65 in early macular degeneration. This study, focusing on early macular degeneration, provides a model for the use of TAs in age-related disease. METHOD: Thirty-eight (38) patients were randomly assigned to a 1-year, double-blinded, placebo-controlled interventional study with arms for oral TA-65 or placebo. Macular functions via micro-perimetry were the primary measured outcomes. RESULTS: The macular function in the arm receiving the TA-65 showed significant improvement relative to the placebo control. The improvement was manifest at 6 months and was maintained at 1 year: macular threshold sensitivity (measured as average dB [logarithmic decibel scale of light attenuation]) improved 0.97 dB compared to placebo (P-value 0.02) and percent reduced thresholds lessened 8.2% compared to the placebo arm (P-value 0.04). CONCLUSION: The oral TA significantly improved the macular function of treatment subjects compared to controls. Although this study was a pilot and a larger study is being planned, it is noteworthy in that it is, to our knowledge, the first randomized placebo-controlled study of a TA supplement.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“a double-blinded study of a small number of patients with early AMD showed that treatment with a telomerase activator significantly improved macular function176”
From Telomere dysfunction in ageing and age-related diseases (2022) · cites this paper as [176]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Repertoires of Autophagy in the Pathogenesis of Ocular Diseases
Li, Y.-J., Jiang, Q., Cao, G.-F., Yao, J., & Yan, B. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000373980 · Cited by 16,304
Telomeres shorten during ageing of human fibroblasts
Harley, C. B., Futcher, A. B., & Greider, C. W. (1990) · Nature · doi:10.1038/345458a0 · Cited by 5,750
Self-citationExtension of Life-Span by Introduction of Telomerase into Normal Human Cells
Bodnar, A. G., Ouellette, M., Frolkis, M., Holt, S. E., Chiu, C.-P., Morin, G. B., Harley, C. B., Shay, J. W., Lichtsteiner, S., & Wright, W. E. (1998) · Science · doi:10.1126/science.279.5349.349 · Cited by 4,975
Self-citationPrevalence of Age-Related Macular Degeneration in the United States
(2004) · Archives of Ophthalmology · doi:10.1001/archopht.122.4.564 · Cited by 2,736
Four faces of cellular senescence
Rodier, F., & Campisi, J. (2011) · Journal of Cell Biology · doi:10.1083/jcb.201009094 · Cited by 2,070
The Role of Oxidative Stress in the Pathogenesis of Age-Related Macular Degeneration
Beatty, S., Koh, H.-H., Phil, M., Henson, D., & Boulton, M. (2000) · Survey of Ophthalmology · doi:10.1016/s0039-6257(00)00140-5 · Cited by 2,051
Clinical Classification of Age-related Macular Degeneration
Ferris, F. L., Wilkinson, C. P., Bird, A., Chakravarthy, U., Chew, E., Csaky, K., & Sadda, S. R. (2013) · Ophthalmology · doi:10.1016/j.ophtha.2012.10.036 · Cited by 1,863
Age-related macular degeneration
Jager, R. D., Mieler, W. F., & Miller, J. W. (2008) · New England Journal of Medicine · doi:10.1056/nejmra0801537 · Cited by 1,379
Telomerase Mutations in Families with Idiopathic Pulmonary Fibrosis
Armanios, M. Y., Chen, J. J.-L., Cogan, J. D., Alder, J. K., Ingersoll, R. G., Markin, C., Lawson, W. E., Xie, M., Vulto, I., Phillips, J. A., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa066157 · Cited by 1,357
Prevalence of Open-Angle Glaucoma Among Adults in the United States
(2004) · Archives of Ophthalmology · doi:10.1001/archopht.122.4.532 · Cited by 1,110
Risk factors for age-related macular degeneration
Smith, W., Assink, J., Klein, R., Mitchell, P., Klaver, C. C. W., Klein, B. E. K., Hofman, A., Jensen, S., Wang, J. J., & de Jong, P. T. V. M. (2001) · Ophthalmology · doi:10.1016/s0161-6420(00)00580-7 · Cited by 1,071
Telomere end-replication problem and cell aging
Levy, M. Z., Allsopp, R. C., Futcher, A. B., Greider, C. W., & Harley, C. B. (1992) · Journal of Molecular Biology · doi:10.1016/0022-2836(92)90096-3 · Cited by 1,069
Self-citationKurz, D. J., Decary, S., Hong, Y., & Erusalimsky, J. D. (2000) · Journal of Cell Science · doi:10.1242/jcs.113.20.3613 · Cited by 899
Mild hyperoxia shortens telomeres and inhibits proliferation of fibroblasts: a model for senescence?
von Zglinicki, T., Saretzki, G., Döcke, W., & Lotze, C. (1995) · Experimental Cell Research · doi:10.1006/excr.1995.1305 · Cited by 856
Absence of cancer–associated changes in human fibroblasts immortalized with telomerase
Morales, C. P., Holt, S. E., Ouellette, M., Kaur, K. J., Yan, Y., Wilson, K. S., White, M. A., Wright, W. E., & Shay, J. W. (1999) · Nature Genetics · doi:10.1038/5063 · Cited by 803
Microarray analysis of replicative senescence
Shelton, D. N., Chang, E., Whittier, P. S., Choi, D., & Funk, W. D. (1999) · Current Biology · doi:10.1016/s0960-9822(99)80420-5 · Cited by 764
Regulated expression of telomerase activity in human T lymphocyte development and activation.
Weng, N. P., Levine, B. L., June, C. H., & Hodes, R. J. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.6.2471 · Cited by 403
Telomeres and age-related disease: how telomere biology informs clinical paradigms
Armanios, M. (2013) · Journal of Clinical Investigation · doi:10.1172/jci66370 · Cited by 347
Immune aging, dysmetabolism, and inflammation in neurological diseases
Deleidi, M., Jäggle, M., & Rubino, G. (2015) · Frontiers in Neuroscience · doi:10.3389/fnins.2015.00172 · Cited by 260
Microperimetry and fundus autofluorescence in patients with early age-related macular degeneration
Midena, E., Vujosevic, S., Convento, E., Manfre', A., Cavarzeran, F., & Pilotto, E. (2007) · British Journal of Ophthalmology · doi:10.1136/bjo.2007.119685 · Cited by 255
Telomeres and Telomerase: The Means to the End (Nobel Lecture)
Blackburn, E. H. (2010) · Angewandte Chemie International Edition · doi:10.1002/anie.201002387 · Cited by 226
Owen, C. G. (2003) · British Journal of Ophthalmology · doi:10.1136/bjo.87.3.312 · Cited by 210
Kinnunen, K., Petrovski, G., Moe, M. C., Berta, A., & Kaarniranta, K. (2012) · Acta Ophthalmologica · doi:10.1111/j.1755-3768.2011.02179.x · Cited by 197
Telomere shortening in human diseases
Kong, C. M., Lee, X. W., & Wang, X. (2013) · The FEBS Journal · doi:10.1111/febs.12326 · Cited by 194
Telomerase-Based Pharmacologic Enhancement of Antiviral Function of Human CD8+ T Lymphocytes
Fauce, S. R., Jamieson, B. D., Chin, A. C., Mitsuyasu, R. T., Parish, S. T., Ng, H. L., Ramirez Kitchen, C. M., Yang, O. O., Harley, C. B., & Effros, R. B. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.10.7400 · Cited by 170
Self-citationRegulatory role of HIF-1α in the pathogenesis of age-related macular degeneration (AMD)
Arjamaa, O., Nikinmaa, M., Salminen, A., & Kaarniranta, K. (2009) · Ageing Research Reviews · doi:10.1016/j.arr.2009.06.002 · Cited by 164
Valdes, A. M., Richards, J. B., Gardner, J. P., Swaminathan, R., Kimura, M., Xiaobin, L., Aviv, A., & Spector, T. D. (2007) · Osteoporosis International · doi:10.1007/s00198-007-0357-5 · Cited by 164
Healthy aging and disease: role for telomere biology?
Zhu, H., Belcher, M., & van der Harst, P. (2011) · Clinical Science · doi:10.1042/cs20100385 · Cited by 161
Inflammatory signaling and cellular senescence
Ren, J.-L., Pan, J.-S., Lu, Y.-P., Sun, P., & Han, J. (2009) · Cellular Signalling · doi:10.1016/j.cellsig.2008.10.011 · Cited by 148
Intrasession Test–Retest Variability of Microperimetry in Age-Related Macular Degeneration
Wu, Z., Ayton, L. N., Guymer, R. H., & Luu, C. D. (2013) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.13-12617 · Cited by 134
Senescence-associated beta-galactosidase histochemistry for the primate eye.
Mishima, K., Handa, J. T., Aotaki-Keen, A. E., Lutty, G. A., Morse, L. S., & Hjelmeland, L. M. (1999) · PubMed · Cited by 126
From cellular senescence to Alzheimer’s disease: The role of telomere shortening
Boccardi, V., Pelini, L., Ercolani, S., Ruggiero, C., & Mecocci, P. (2015) · Ageing Research Reviews · doi:10.1016/j.arr.2015.04.003 · Cited by 121
Psychophysical Function in Age-related Maculopathy
Neelam, K., Nolan, J. M., Chakravarthy, U., & Beatty, S. (2009) · Survey of Ophthalmology · doi:10.1016/j.survophthal.2008.12.003 · Cited by 120
Human lens cells have an in vitro proliferative capacity inversely proportional to the donor age
Tassin, J., Malaise, E. P., & Courtois, Y. (1979) · Experimental Cell Research · doi:10.1016/0014-4827(79)90483-x · Cited by 102
Beta-galactosidase histochemistry and telomere loss in senescent retinal pigment epithelial cells.
Matsunaga, H., Handa, J. T., Aotaki-Keen, A. E., Sherwood, S. W., West, M. D., & Hjelmeland, L. M. (1999) · PubMed · Cited by 101
Harley, C. B., Liu, W., Flom, P. L., & Raffaele, J. M. (2013) · Rejuvenation Research · doi:10.1089/rej.2013.1430 · Cited by 100
Self-citationTelomeres and cardiovascular disease risk: an update 2013
Nilsson, P. M., Tufvesson, H., Leósdóttir, M., & Melander, O. (2013) · Translational research · doi:10.1016/j.trsl.2013.05.004 · Cited by 91
Eisner, A., Stoumbos, V. D., Klein, M. L., & Fleming, S. A. (1991) · PubMed · Cited by 90
Besharse, J. C., & Pfenninger, K. H. (1980) · The Journal of cell biology · doi:10.1083/jcb.87.2.451 · Cited by 88
Telomere Dysfunction and Cell Senescence in Chronic Lung Diseases: Therapeutic Potential
Adnot, S., Amsellem, V., Boyer, L., Marcos, É., Saker, M., Houssaini, A., Kebe, K., Dagouassat, M., Lipskaia, L., & Boczkowski, J. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2015.06.007 · Cited by 72
Risk factors for agerelated macular degeneration: Pooled findings from three continents
Smith, W., Assink, J. (., Klein, R., Mitchell, P., Klaver, C., Klein, B., Albert Hofman, D., Jensen, S., Wang, J., & Jong, P. D. (2001) · KNAW research portal (Royal Academy of Art and Sciences (KNAW)) · Cited by 70
Rastmanesh, R. (2010) · Medical Hypotheses · doi:10.1016/j.mehy.2010.08.036 · Cited by 49
Dietary safety of cycloastragenol from Astragalus spp.: Subchronic toxicity and genotoxicity studies
Szabo, N. J. (2013) · Food and Chemical Toxicology · doi:10.1016/j.fct.2013.11.041 · Cited by 48
Macular drusen and the sensitivity of the central visual field
Midena, E., Segato, T., Blarzino, M. C., & Angeli, C. D. (1994) · Documenta Ophthalmologica · doi:10.1007/bf01204616 · Cited by 46
Functional outcome of macular edema in different retinal disorders
Tomkins‐Netzer, O., Ismetova, F., Bar, A., Seguin‐Greenstein, S., Kramer, M., & Lightman, S. (2015) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2015.05.002 · Cited by 37
Zhao, L., Wang, Z., Liu, Y., Song, Y., Li, Y., Laties, A. M., & Wen, R. (2007) · PubMed Central · Cited by 29
Weng, X., Zhang, H., Kan, M., Ye, J., Liu, F., Wang, T., Deng, J., Tan, Y., He, L., & Liu, Y. (2015) · Experimental Gerontology · doi:10.1016/j.exger.2015.06.004 · Cited by 27
Possible therapy for age-related macular degeneration using human telomerase
Rowe-Rendleman, C. L., & Glickman, R. D. (2003) · Brain Research Bulletin · doi:10.1016/s0361-9230(03)00072-8 · Cited by 21
Age-related macular degeneration
Richter, C., & Shaban, H. (2009) · Hamdan Medical Journal · doi:10.4103/2227-2437.231292 · Cited by 18
Ultimate Fate of Rod Outer Segments in the Retinal Pigment Epithelium
Thumann, G., Bartz‐Schmidt, K. U., Kociok, N., Heimann, K., & SCHRAEMEYER, U. (1999) · Pigment Cell Research · doi:10.1111/j.1600-0749.1999.tb00764.x · Cited by 15
Park, J., Kim, B., Han, Y. S., & Park, I. K. (2002) · Experimental & Molecular Medicine · doi:10.1038/emm.2002.16 · Cited by 14
Ocular Nutritional Supplements
Yong, J. J., Scott, I. U., & Greenberg, P. B. (2014) · Ophthalmology · doi:10.1016/j.ophtha.2014.09.039 · Cited by 11
(2002) · PubMed
Cited by
Telomere dysfunction in ageing and age-related diseases
Rossiello, F., Jurk, D., Passos, J. F., & d’Adda di Fagagna, F. (2022) · Nature Cell Biology · doi:10.1038/s41556-022-00842-x · Cited by 754
Telomeres: history, health, and hallmarks of aging
Chakravarti, D., LaBella, K. A., & DePinho, R. A. (2021) · Cell · doi:10.1016/j.cell.2020.12.028 · Cited by 637
Age-related macular degeneration: A two-level model hypothesis
Rozing, M. P., Durhuus, J. A., Krogh Nielsen, M., Subhi, Y., Kirkwood, T. B., Westendorp, R. G., & Sørensen, T. L. (2020) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2019.100825 · Cited by 180
Anti-aging pharmacology: Promises and pitfalls
Vaiserman, A. M., Lushchak, O. V., & Koliada, A. K. (2016) · Ageing Research Reviews · doi:10.1016/j.arr.2016.08.004 · Cited by 151
Therapeutic Targeting of Telomerase
Jäger, K., & Walter, M. (2016) · Genes · doi:10.3390/genes7070039 · Cited by 139
Metadata
- Authors
- Dow, C. T., & Harley, C.
- Affiliations
- University of Wisconsin–Madison (US)
- Corresponding author
- Dow, Coad Thomas
- ORCID
- Dow, Coad Thomas
- Venue
- Clinical Ophthalmology
- Publisher
- Informa UK Limited
- Published
- 2016-01
- Volume
- 10
- Pages
- 243
- ISSN
- 1177-5467 (ISSN-L)
- 1177-5483
- PMC
- PMC4734847
- OpenAlex
- W2294620921
- Cited by
- 56
- References
- 56
- Citations by year
- 2026: 1 · 2025: 3 · 2024: 5 · 2023: 7 · 2022: 10 · 2021: 10 · 2020: 9 · 2019: 3 · 2018: 4 · 2017: 1 · 2016: 3
- FWCI
- 3.89
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Clinical ophthalmology (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Dove Medical Press (Taylor and Francis Group) (submittedVersion, cc-by-nc)
- Topics
- Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Health Sciences › Medicine › Ophthalmology › Retinal Development and Disorders
- Keywords
- age-related macular degeneration, telomerase activators, retinal pigment epithelium, cellular senescence, telomere shortening, macular function, microperimetry, dietary supplements
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.